1. Home
  2. HRTG vs EVMN Comparison

HRTG vs EVMN Comparison

Compare HRTG & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$23.21

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$22.13

Market Cap

825.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRTG
EVMN
Founded
2012
2020
Country
United States
United States
Employees
N/A
48
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
825.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
HRTG
EVMN
Price
$23.21
$22.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$33.50
$43.88
AVG Volume (30 Days)
442.0K
308.6K
Earning Date
05-07-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
214.43
N/A
EPS
1.19
N/A
Revenue
$847,330,000.00
N/A
Revenue This Year
$7.50
N/A
Revenue Next Year
$6.74
N/A
P/E Ratio
$19.53
N/A
Revenue Growth
3.71
N/A
52 Week Low
$16.83
$13.89
52 Week High
$31.98
$33.20

Technical Indicators

Market Signals
Indicator
HRTG
EVMN
Relative Strength Index (RSI) 38.27 41.98
Support Level $22.46 $21.39
Resistance Level $28.55 $23.08
Average True Range (ATR) 1.33 1.42
MACD -0.37 -0.21
Stochastic Oscillator 25.73 25.45

Price Performance

Historical Comparison
HRTG
EVMN

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: